Literature DB >> 4617745

An extended clinical trial to compare levodopa and amantadine used as single drugs with both drugs used incombination in Parkinson's Disease.

N Calaghan, M McIlroy, M O'Connor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4617745     DOI： 10.1007/bf03004744

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN： 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  13 in total

1.  Treatment of parkinsonism by amantadine and levodopa.

Authors:  C Mawdsley; I R Williams; I A Pullar; D L Davidson; N E Kinloch
Journal:  Clin Pharmacol Ther       Date:  1972 Jul-Aug       Impact factor: 6.875

2.  Treatment of Parkinson's Disease with levodopa and amantadine used as single drugs and in combined therapy.

Authors:  N Callagham; M Mcllroy; M O'Connor
Journal:  Ir J Med Sci       Date:  1974-03       Impact factor: 1.568

3.  Treatment of Parkinson's disease with amantadine and levodopa. A one-year study.

Authors:  J D Parkes; R C Baxter; G Curzon; R P Knill-Jones; P J Knott; C D Marsden; R Tattersall; D Vollum
Journal:  Lancet       Date:  1971-05-29       Impact factor: 79.321

4.  Combined treatment of Parkinson's disease with amantadine and L-dopa.

Authors:  G Scotti
Journal:  Lancet       Date:  1970-06-27       Impact factor: 79.321

5.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

6.  Amantadine in Parkinsonism. An extended prospective trial.

Authors:  N S Rao; J Pearce
Journal:  Practitioner       Date:  1971-02

7.  Amantadine in Parkinson's disease. Review of more than two years' experience.

Authors:  R S Schwab; D C Poskanzer; A C England; R R Young
Journal:  JAMA       Date:  1972-11-13       Impact factor: 56.272

8.  Treatment of parkinsonism with levodopa. Follow-up after 2 years of treatment.

Authors:  J E Lee; R D Sweet; F H McDowell
Journal:  Ann Intern Med       Date:  1971-11       Impact factor: 25.391

9.  An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.

Authors:  R J Mones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

Review 10.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262
View more
  1 in total

Review 1.  Amantadine in Parkinson's disease.

Authors:  N Crosby; K H Deane; C E Clarke
Journal:  Cochrane Database Syst Rev       Date:  2003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.